Flaminia Campo
Papers
2
Total Citations
40
H-Index
2
About
Dr. Flaminia Campo is a leading clinician-scientist in head and neck oncology, whose work centers on optimizing functional outcomes and personalizing treatment for oropharyngeal squamous cell carcinoma (OPSCC). Her major contributions bridge the gap between surgical innovation and quality of life, most notably through her landmark 2023 study comparing swallowing quality after transoral robotic surgery (TORS) versus radiotherapy—a paper that has already garnered 33 citations and reshaped clinical decision-making for patients with OPSCC. More recently, Dr. Campo has pioneered the use of liquid biopsy technology, demonstrating in her 2025 study that circulating HPV DNA can serve as a molecular marker for residual disease following TORS. This work, with 7 citations in its first year, positions her at the forefront of precision oncology, offering a non-invasive tool to detect recurrence earlier than conventional imaging. Her research not only advances surgical techniques but also integrates molecular diagnostics to improve surveillance and reduce overtreatment. Dr. Campo’s work is essential reading for any student or researcher interested in the future of de-escalation strategies, functional preservation, and biomarker-driven care in head and neck cancer.
Research Focus
Key Achievements
Top Papers
- 1
- 2